{"anticipatedPostingDate":"2027-09","denomUnitsSelected":"Participants","description":"TTPP was defined as the time from the date of randomization to date of pain progression. Pain progression was defined as a participant reporting either of the following, whichever came first: 1) Increase of 2 or more points from baseline on Brief Pain Inventory - Short Form (BPI-SF) Question 3 (i.e., pain at its worst in the last 24 hours, score range 0 to 10 with higher scores associated with higher pain levels) maintained for at least two consecutive assessments. 2) Initiation of new opioid medication from baseline for pain with usage maintained for at least two consecutive assessments as recorded in BPI-SF Question 7 (i.e., What medications received for pain).","reportingStatus":"NOT_POSTED","timeFrame":"From the date of randomization to date of pain progression (maximum up to approximately 7.4 years)","title":"Time to Pain Progression (TTPP)","type":"SECONDARY"}